Welcome, Guest. Please login or register.
Did you miss your activation email?
2012-May-28, 03:16 AM

Login with username, password and session length

Racehorse TALK

Pages: [1]   Go Down
 
Author Topic: Compulsory treatment recording in racing stables  (Read 250 times)
0 Members and 2 Guests are viewing this topic.
InTheKnow
Group 2
user 400
Offline Offline
Posts: 2645
Original Post 2009-Sep-16, 09:31 AM

Tuesday, 15 September 2009
New rule requiring compulsory treatment recording in racing stables
Trainers and other industry participants are notified of the introduction of AR.178F, effective 1 September 2009, which makes compulsory for trainers the keeping of accurate records of any and all treatments administered to racehorses in their care. AR.178F reads:

“AR.178F

(1) A trainer must keep, and retain for a period of twelve months, a record of any treatment administered to any horse in his care. Each record of treatment must, as a minimum requirement, include the following information:

(a) name of the horse;
(b) date of administration of the treatment;
(c) name of the treatment (brand name or active constituent);
(d) route of administration;
(e) amount given;
(f) name and signature of person or persons administering and/or authorising treatment.

(2) For the purposes of this rule “treatment” includes:

(a) all Controlled Drugs (Schedule cool administered by a veterinarian;

(b) all Prescription Animal Remedies (Schedule 4), including those listed in AR.178C(2);

(c) all Prescription Only Medicines (Schedule 4), prescribed and/or dispensed by a veterinarian for off-label use;

(d) all injectable veterinary medicines (intravenous, intramuscular, subcutaneous, intra-articular) not already included above;

(e) all Pharmacist Only (Schedule 3) and Pharmacy Only
(Schedule 2) medicines;

(f) all veterinary and other medicines containing other scheduled and unscheduled prohibited substances;

(g) all alkalinising agents;

(h) all herbal preparations.

(3) When requested, the records of treatment kept by trainers in accordance with the provisions of subrule (1) must be made available to the Stewards.”

These records must be retained for at least 12 months and be produced if requested by the Stewards, for example, during a stable inspection or at an official Stewards’ inquiry.

Provided the required details as specified in AR.178F are entered for each treatment, there is currently no prescribed format for the recording of treatment. This is because methods of record keeping for invoicing and other purposes vary from stable to stable, depending on the size and complexity of the operation.

Suggested methods include the use of an A4 day-to-a-page diary where the required treatment details are entered daily for each horse on the corresponding page. Columns on each page would include racing name of horse, treatment administered, route of administration (oral, IV, etc), amount given, name and signature of person administering treatment, and name of person authorising treatment.

Alternatively, an A4 or similar-sized page-numbered account book might be used to enter the required treatment details on a page (or pages) for each horse in consecutive order as treatments are administered, ensuring the same details under the headings specified above are recorded, but also including the date of administration.

Electronic records using appropriate computer software are also acceptable, provided the required details as specified in AR.178F are entered, especially including the name of the person administering and/or authorising the treatment.

It is anticipated, as shown in overseas jurisdictions, that compulsory treatment recording will improve stable medication practices more generally, and will hopefully reduce the incidence of inadvertent positives to therapeutic medications (the vast majority of “positive swabs” in racing). Recording all treatments, including herbal and other preparations, can also be of assistance to both trainers and Stewards where accidental contamination of a product with a prohibited substance may have occurred during manufacture.

Logged
 
InTheKnow
Group 2
user 400
Offline Offline
Posts: 2645
2009-Sep-16, 09:48 AM

Tuesday, 15 September 2009
Warning on the use of hydrocortisone sodium succinate (Solu-Cortef) within 48 hours of racing
As from 1 November 2009, a new testing method will be introduced by the Australian racing laboratories which will allow the direct detection of hydrocortisone hemisuccinate (arising from the use of hydrocortisone sodium succinate) in blood and urine. This method does not require quantitative measurement of the hydrocortisone concentration and the application of the urinary threshold specified in AR.178C(1)(f).

The method detects recent use of the human prescription medicine Solu-Cortef whose active ingredient is hydrocortisone sodium succinate and which therefore should not be used within 48 hours of racing. This method can be extended to cover other injectable forms of hydrocortisone although none of these are currently registered for use in Australia.

Industry participants are therefore advised to avoid the use of hydrocortisone sodium succinate within the 48 hours prior to racing, and are also advised that the detection of hydrocortisone hemisuccinate in a blood or urine sample at any concentration constitutes a breach of the Australian Rules of Racing. Further, the urinary threshold for hydrocortisone in AR 178C(1)(f) does not apply to hydrocortisone hemisuccinate.
Logged
Pages: [1]   Go Up
 
 
Jump to:  

 - Links - Luxbet Horse Racing Betting - Racenet - Horse Racing - Noms and Acc - QTAB - TAB Horse Racing Betting - Racing and Sports - Horse Racing Only
Powered by SMF 1.1.15 | SMF © 2011, Simple Machines
TinyPortal v0.9.8 © Bloc | Adagio design by Bloc